Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1

Butler Hospital

Status and phase: Terminated; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Risperidone

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; NIH

Identifiers

NCT00000309

R01DA009330 (U.S. NIH Grant/Contract)

R01-09330-1

NIDA-09330-1

Details and patient eligibility

About

The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.